Dec 9 (Reuters) – Indianapolis-based pharmaceutical giant Eli Lilly and Co. said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, ...
(Reuters) - Indianapolis-based drugmaker Lilly said on Monday it plans to build a new $3 billion manufacturing plant in the Netherlands to expand the production capacity for its keenly watched ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results